Why the study?
Does antidepressant treatment predict increased mortality in ambulatory care patients?
Does antidepressant treatment predict increased mortality in ambulatory care patients?
Antidepressant treatment in ambulatory patients, particularly those over 65 or with baseline ischemic heart disease, is associated with increased long-term all-cause and cardiovascular mortality.
May warrant caution prescribing antidepressants to older patients with ischemic heart disease; leaves open causality versus confounding.
BACKGROUND: Non-institutionalised patients treated with antidepressants have been shown to have indicators of a generalised vulnerability, such as high rates of health service use and excessive prescription drug use. Therefore, mortality in this patient group is of interest. METHOD: All first-incidence antidepressant users in a defined population during a five-year period were identified. Their total mortality during a nine-year follow-up was analysed. Cox proportional hazards regression was used to analyse total mortality, and mortality in cardiovascular disease, controlling for baseline chronic medical disease. RESULTS: Antidepressant treatment at the index date was a statistically significant predictor for increased long-term mortality in the over-65s, even when controlling for pre-existing chronic medical disease. Baseline ischaemic heart disease and concurrent antidepressant treatment significantly predicted mortality from cardiovascular causes. CONCLUSION: Prescribed antidepressant treatment identifies patients who are at risk of increased mortality. For the physician in ambulatory care, knowledge of a patient's antidepressant treatment history may be a valuable tool in managing patient care.
No takes yet. Share an insight, caveat, or question.
Bingefors et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: